506 related articles for article (PubMed ID: 12425654)
1. Compatibilization effect of poly(epsilon-caprolactone)-b-poly(ethylene glycol) block copolymers and phase morphology analysis in immiscible poly(lactide)/poly(epsilon-caprolactone) blends.
Na YH; He Y; Shuai X; Kikkawa Y; Doi Y; Inoue Y
Biomacromolecules; 2002; 3(6):1179-86. PubMed ID: 12425654
[TBL] [Abstract][Full Text] [Related]
2. Melt Crystallization Behavior and Crystalline Morphology of Polylactide/Poly(ε-caprolactone) Blends Compatibilized by Lactide-Caprolactone Copolymer.
Zhang C; Lan Q; Zhai T; Nie S; Luo J; Yan W
Polymers (Basel); 2018 Oct; 10(11):. PubMed ID: 30961106
[TBL] [Abstract][Full Text] [Related]
3. Toughening Poly(l-lactide) Blends: Effectiveness of Sequence-Controlled Six-Arm Star-Branched Block Copolymers of Poly(l-lactide) and Poly(ε-caprolactone).
Deokar MD; Garnaik B; Sivaram S
ACS Omega; 2022 Mar; 7(11):9118-9129. PubMed ID: 35350312
[TBL] [Abstract][Full Text] [Related]
4. Immiscible poly(lactic acid)/poly(ε-caprolactone) for temporary implants: Compatibility and cytotoxicity.
Finotti PF; Costa LC; Capote TS; Scarel-Caminaga RM; Chinelatto MA
J Mech Behav Biomed Mater; 2017 Apr; 68():155-162. PubMed ID: 28171812
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of star poly(epsilon-caprolactone)-b-poly(ethylene glycol) and poly(L-lactide)-b-poly(ethylene glycol) copolymers: evaluation as drug delivery carriers.
Wang F; Bronich TK; Kabanov AV; Rauh RD; Roovers J
Bioconjug Chem; 2008 Jul; 19(7):1423-9. PubMed ID: 18564869
[TBL] [Abstract][Full Text] [Related]
6. Poly(ε-Caprolactone)/Poly(Lactic Acid) Blends Compatibilized by Peroxide Initiators: Comparison of Two Strategies.
Przybysz-Romatowska M; Haponiuk J; Formela K
Polymers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963365
[TBL] [Abstract][Full Text] [Related]
7. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of hydrophilicity, biocompatibility and biodegradability of poly(ε-caprolactone) electrospun nanofiber scaffolds using poly(ethylene glycol) and poly(L-lactide-co-ε-caprolactone-co-glycolide) as additives for soft tissue engineering.
Arbade GK; Srivastava J; Tripathi V; Lenka N; Patro TU
J Biomater Sci Polym Ed; 2020 Sep; 31(13):1648-1670. PubMed ID: 32402230
[TBL] [Abstract][Full Text] [Related]
9. Protein release from water-swellable poly(D,L-lactide-PEG)-b-poly(ϵ-caprolactone) implants.
Stanković M; Hiemstra C; de Waard H; Zuidema J; Steendam R; Frijlink HW; Hinrichs WL
Int J Pharm; 2015 Mar; 480(1-2):73-83. PubMed ID: 25575472
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cell affinity on poly(L-lactide) and poly(epsilon-caprolactone) blends and on PLLA-b-PCL diblock copolymer surfaces.
Ajami-Henriquez D; Rodríguez M; Sabino M; Castillo RV; Müller AJ; Boschetti-de-Fierro A; Abetz C; Abetz V; Dubois P
J Biomed Mater Res A; 2008 Nov; 87(2):405-17. PubMed ID: 18186046
[TBL] [Abstract][Full Text] [Related]
11. Morphological control of poly(ethylene glycol)-block-poly(epsilon-caprolactone) copolymer aggregates in aqueous solution.
Fairley N; Hoang B; Allen C
Biomacromolecules; 2008 Sep; 9(9):2283-91. PubMed ID: 18702541
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system.
Zhou S; Deng X; Yang H
Biomaterials; 2003 Sep; 24(20):3563-70. PubMed ID: 12809785
[TBL] [Abstract][Full Text] [Related]
13. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
14. Effect of phase structure on enzymatic degradation in poly(L-lactide)/atactic poly(3-hydroxybutyrate) blends with different miscibility.
Kikkawa Y; Suzuki T; Kanesato M; Doi Y; Abe H
Biomacromolecules; 2009 Apr; 10(4):1013-8. PubMed ID: 19298077
[TBL] [Abstract][Full Text] [Related]
15. Study of the synthesis, crystallization, and morphology of poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers.
He C; Sun J; Deng C; Zhao T; Deng M; Chen X; Jing X
Biomacromolecules; 2004; 5(5):2042-7. PubMed ID: 15360322
[TBL] [Abstract][Full Text] [Related]
16. Experimental evidence for immiscibility of enantiomeric polymers: Phase separation of high-molecular-weight poly(ʟ-lactide)/poly(ᴅ-lactide) blends and its impact on hindering stereocomplex crystallization.
Chen Y; Lan Q
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129459. PubMed ID: 38232890
[TBL] [Abstract][Full Text] [Related]
17.
Conde G; de Carvalho JRG; Dias PDP; Moranza HG; Montanhim GL; Ribeiro JO; Chinelatto MA; Moraes PC; Taboga SR; Bertolo PHL; Gonçalves Funnicelli MI; Pinheiro DG; Ferraz GC
Biomed Phys Eng Express; 2021 Mar; 7(3):. PubMed ID: 33652429
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Characterization of Double Crystalline Cyclic Diblock Copolymers of Poly(ε-caprolactone) and Poly(l(d)-lactide) (c(PCL-b- PL(D)LA)).
Liénard R; Zaldua N; Josse T; Winter J; Zubitur M; Mugica A; Iturrospe A; Arbe A; Coulembier O; Müller AJ
Macromol Rapid Commun; 2016 Oct; 37(20):1676-1681. PubMed ID: 27568984
[TBL] [Abstract][Full Text] [Related]
19. Preparation and drug loading of poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles through the evaporation of a cosolvent azeotrope.
Jette KK; Law D; Schmitt EA; Kwon GS
Pharm Res; 2004 Jul; 21(7):1184-91. PubMed ID: 15290858
[TBL] [Abstract][Full Text] [Related]
20. Effect of poly ethylene glycol on the mechanical and thermal properties of bioactive poly(ε-caprolactone) melt extrudates for pharmaceutical applications.
Douglas P; Albadarin AB; Sajjia M; Mangwandi C; Kuhs M; Collins MN; Walker GM
Int J Pharm; 2016 Mar; 500(1-2):179-86. PubMed ID: 26794874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
